{
  "docId": "019de075-3207-70ec-93a8-5bb5ec3d9629",
  "docSlug": "951aacbbe982699d0f743a597a954ece",
  "documentTitle": "OKYO Pharma | Results Presentation Deck | 25 slides",
  "authorId": "okyo-pharma",
  "authorName": "OKYO Pharma",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 13,
  "pageCount": 25,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "before_after",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 5,
  "notes": "The chart shows that OK-101 (0.04%) reduces corneal permeability to levels comparable to Cyclosporine (0.1%) and significantly better than the phosphate buffer control.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-3207-70ec-93a8-5bb5ec3d9629/13",
  "deckHref": "/decks/019de075-3207-70ec-93a8-5bb5ec3d9629",
  "deckJsonHref": "/decks/019de075-3207-70ec-93a8-5bb5ec3d9629.json",
  "deckAnchorHref": "/decks/019de075-3207-70ec-93a8-5bb5ec3d9629#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.28,
        "x": 0.7,
        "y": 0.75
      },
      "kind": "callout",
      "text": "Reducing corneal permeability with OK-101 improves corneal integrity in dry eye mouse model",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0b98a00d-2922-4fcf-a41d-d206f2d93c95",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.6,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Corneal Permeability bar chart",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "64386793-2099-4e6c-a7a0-aa8d53743895",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.12,
        "x": 0.78,
        "y": 0.15
      },
      "kind": "image",
      "text": "Mouse icon",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8cc16594-efdc-40ab-9325-a84393726f10",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.28,
        "x": 0.7,
        "y": 0.3
      },
      "kind": "list",
      "text": "OK-101 and cyclosporine were administered topically twice a day. Corneal permeability significantly reduced with OK-101 vs phosphate buffer alone. Potency of OK-101 was comparable to cyclosporine.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1baa00b8-07f7-455b-9c8e-e56195bc4682",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.12,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "*Patil et al. (2019) 14th Congress on Ocular Pharmacology and Therapeutics, New Orleans, LA",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3f9052e1-9186-4f25-adcf-f1f23a114f76",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "Validation: OK-101 Efficacy in Dry Eye Mouse Model",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "21bf384f-675e-4540-8788-198fa9b753a7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 14,
      "from": 12,
      "name": "Before After",
      "slug": "21-before-after",
      "bestFor": "Product demos, process improvements, ROI justification",
      "matchId": "f0d99e36-d306-4765-a11c-43f2ebbc73e0",
      "evidence": "Slides 12-14 show before-after comparisons of OK-101's effectiveness in in-vitro studies and mouse models.",
      "position": 0,
      "objective": "Demonstrate OK-101's efficacy",
      "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta",
      "confidence": 0.7,
      "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}